Restoration of the cellular senescence program and repression of telomerase by human chromosome 3.
Telomeres, at the end of chromosomes, shorten with each cell division, resulting in cellular senescence. Tumor cells, unlike normal somatic cells, express a telomerase that maintains the telomere length. Deletion of a gene(s) on chromosome 3 is common in human renal cell carcinoma (RCC) and reintroduction of a normal chromosome 3 into an RCC immortal cell line restored the program of cellular senescence. The loss of indefinite growth potential was associated with the loss of telomerase activity and shortening of telomeres in the RCC cells with a normal chromosome 3. However, microcell hybrids that escaped from senescence and microcell hybrids with an introduced chromosome 7 or 11 maintained telomere lengths and telomerase activity similar to those of the parental RCC23. Thus, restoration of the cellular senescence program by chromosome 3 is associated with repression of telomerase function in RCC cells.
D001483:Base Sequence; D002292:Carcinoma, Renal Cell / Q000201:enzymology / Q000473:pathology; D016922:Cellular Senescence; D002893:Chromosomes, Human, Pair 3; D017931:DNA Primers / Q000737:chemistry; D006801:Humans; D006822:Hybrid Cells; D008969:Molecular Sequence Data; D019098:Telomerase / Q000378:metabolism*; D016615:Telomere / Q000648:ultrastructure*; D014407:Tumor Cells, Cultured
D017931:DNA Primers; D019098:Telomerase